Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc demonstrated strong financial performance, with a notable 6.3% growth in gross margin dollar generation in the latest quarter. The company also exhibited robust capital management by repurchasing $95 million of its own stock, reflecting confidence in its future prospects. Additionally, the chronic therapy segment experienced growth exceeding 10%, alongside an upward revision of key elements in the FY/25 financial guidance, signaling positive momentum for sustained revenue growth and margin expansion.

Bears say

The financial outlook for Option Care Health Inc is negatively impacted by uncertainty regarding the future revenue implications of the Stelara biosimilar, which may result in a gross profit headwind of $25 million to $35 million. Additionally, the company’s reliance on its largest customer, which accounts for 14% of total revenue, poses a significant risk, as losing this account could substantially affect overall profitability. Furthermore, limited gross margin expansion is anticipated due to the growth dynamics of chronic therapies compared to higher-margin acute therapies, challenging future EBITDA margin improvements.

OPCH has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 9 analysts, OPCH has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.